Share chart CVRx, Inc.
Extended chart
Simple chart
About CVRx, Inc.
CVRx, Inc. разрабатывает имплантируемую технологию для лечения пациентов с высоким кровяным давлением / гипертонией и сердечной недостаточностью. Он предлагает BAROSTIM NEO, нейромодуляционную терапию, которая запускает естественный рефлекс организма для регулирования артериального давления и основных причин прогрессирования сердечной недостаточности, которая доставляется через долговременную систему имплантатов и настраивается с учетом индивидуальных потребностей каждого пациента. . Компания обслуживает пациентов и медицинских работников. CVRx, Inc. more details| IPO date | 2021-06-30 |
|---|---|
| ISIN | US1266381052 |
| Industry | Health Care Equipment & Supplies |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.cvrx.com |
| Цена ао | 14.99 |
| Change price per day: | 0% (17.77) |
|---|---|
| Change price per week: | +0.8513% (17.62) |
| Change price per month: | +30.47% (13.62) |
| Change price per 3 month: | +72.69% (10.29) |
| Change price per half year: | +107.84% (8.55) |
| Change price per year: | -33.69% (26.8) |
| Change price per 3 year: | +128.11% (7.79) |
| Change price per 5 year: | 0% (17.77) |
| Change price per 10 year: | 0% (17.77) |
| Change price per year to date: | +30.66% (13.6) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Blackrock Inc. | 765 | 3.54 |
| Balyasny Asset Management LLC | 619 | 2.86 |
| Vanguard Group Inc | 594 | 2.75 |
| Lord, Abbett & Co. LLC | 589 | 2.73 |
| Emerald Advisers, LLC | 488 | 2.26 |
| Emerald Mutual Fund Advisers Trust | 385 | 1.78 |
| Parkman Healthcare Partners LLC | 332 | 1.54 |
| Archon Capital Management LLC | 284 | 1.32 |
| Johnson & Johnson | 4 | 19 |
| NEA Management Company, LLC | 2 | 10.98 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.03065 | 17.09 | 1.54048 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
iShares Russell 2000 Growth ETF
|
0.00893 | 38.04 | 0.6026 |
ProShares UltraPro Russell2000
|
0.00261 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.00071 | 5.92 | 1.47892 |
| iShares Russell 3000 ETF | 0.00032 | 24.83 | 1.43482 |
| Dimensional U.S. Core Equity 2 ETF | 0.00016 | 30.76 | 1.47098 |
| Dimensional US Core Equity Market ETF | 0.00011 | 30.98 | 1.40618 |
| Dimensional U.S. Equity ETF | 0.00004 | 31.53 | 1.3557 |
| Avantis U.S. Equity ETF | 0.00002 | 23.04 | 1.59151 |
| Vanguard Russell 2000 ETF | 0 | 17.16 | 1.48801 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Jared Oasheim | Chief Financial Officer | 446.1k | 1984 (41 year) |
| Mr. Paul Verrastro | Chief Marketing & Strategy Officer | 529.84k | 1963 (62 years) |
| Mr. Paul Pignato | Vice President of Operations | N/A | |
| Ms. Jonelle R. Burnham | VP & General Counsel | N/A | 1971 (54 years) |
| Mr. Kevin Hykes | President, CEO & Director | N/A | 1966 (59 years) |
| Ms. Tonya A. Austin SPHR | Chief Human Resources Officer | 1972 (53 years) | |
| Ms. Jennifer E. Englund | Senior Vice President of Global Clinical Affairs | ||
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer | ||
| Ms. Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | ||
| Mr. Robert Allen John | Chief Revenue Officer |
Address: United States, Minneapolis. MN, 9201 West Broadway Avenue - open in Google maps, open in Yandex maps
Website: https://www.cvrx.com
Website: https://www.cvrx.com
